[Immunological problems in radiotherapy and adjuvant cytostatic chemotherapy of breast cancer].
The possible importance of the immune system in early development and progression of breast cancer is being discussed. The different laboratory methods in controlling the specific and non-specific immune reactivity are summarized. The modificaiton of the immunological parameters by radio- resp. chemotherapy is critically presented on the basis of published data and on own results. An analysis of the data obtained by various immunological methods in respect to their consequences in diagnosis and prognosis is done. An immunological monitoring in the control of radio-, chemo- and immunotherapy in breast cancer patients is proposed.
D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008214:Lymphocytes / Q000276:immunology; D010835:Phytohemagglutinins; D011379:Prognosis
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D010835:Phytohemagglutinins
Immunologische Probleme bei der radiologischen und zytostatischen Zusatzbehandlung des Mammakarzinoms.